Cargando…

The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review

INTRODUCTION: Nonsteroidal anti-inflammatory drugs (NSAIDs) have been the first-line choice for the acute treatment of migraine attacks for decades; however, the safety of a particular NSAID is related to its treatment dose, duration, and mechanism of action. Although adverse event (AE) risks differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ailani, Jessica, Nahas, Stephanie J., Friedman, Deborah I., Kunkel, Todd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199993/ https://www.ncbi.nlm.nih.gov/pubmed/37093356 http://dx.doi.org/10.1007/s40122-023-00501-5

Ejemplares similares

Celecoxib Oral Solution and the Benefits of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Technology: A Narrative Review
por: Silberstein, Stephen, et al.
Publicado: (2023)

Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine
por: Nahas, Stephanie J., et al.
Publicado: (2021)

Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review
por: Martin, Vincent, et al.
Publicado: (2020)

Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure
por: Tepper, Stewart J., et al.
Publicado: (2022)

Gepants for Acute and Preventive Migraine Treatment: A Narrative Review
por: Rissardo, Jamir Pitton, et al.
Publicado: (2022)

Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine—Clinical Considerations: A Narrative Review
por: Ailani, Jessica, et al.
Publicado: (2022)

Real-World Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine
por: Ailani, Jessica, et al.
Publicado: (2022)

Combination CGRP monoclonal antibody and onabotulinumtoxinA treatment for preventive treatment in chronic migraine
por: Ailani, Jessica, et al.
Publicado: (2021)

Ubrogepant in the Acute Management of Migraine: A Narrative Review
por: Chiang, Chia-Chun, et al.
Publicado: (2021)

Risk factors for migraine disease progression: a narrative review for a patient-centered approach
por: Lipton, Richard B., et al.
Publicado: (2023)

The Treatment of Vestibular Migraine: A Narrative Review
por: Shen, Youjin, et al.
Publicado: (2020)

Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial
por: Lipton, Richard B, et al.
Publicado: (2021)

Non-Invasive Neurostimulation Methods for Acute and Preventive Migraine Treatment—A Narrative Review
por: Evers, Stefan
Publicado: (2021)

Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial
por: Ailani, Jessica, et al.
Publicado: (2020)

Fremanezumab: a disease-specific option for the preventive treatment of migraine, including difficult-to-treat migraine
por: Friedman, Deborah I., et al.
Publicado: (2020)

Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
por: Blumenfeld, Andrew M., et al.
Publicado: (2023)

Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib
por: Sobolewski, Cyril, et al.
Publicado: (2021)

Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Lipton, Richard B., et al.
Publicado: (2019)

Visual Perception in Migraine: A Narrative Review
por: Hadjikhani, Nouchine, et al.
Publicado: (2021)

Central Sensitization in Migraine: A Narrative Review
por: Suzuki, Keisuke, et al.
Publicado: (2022)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura
por: Lipton, Richard B, et al.
Publicado: (2021)

Clinical Evidence of Cannabinoids in Migraine: A Narrative Review
por: Lo Castro, Flavia, et al.
Publicado: (2022)

Efficacy and safety of celecoxib on the incidence of recurrent colorectal adenomas: a systematic review and meta-analysis
por: Veettil, Sajesh K, et al.
Publicado: (2019)

A Narrative Review of Neuroimaging Studies in Acupuncture for Migraine
por: Ma, Peihong, et al.
Publicado: (2021)

Patient preference for early onset of efficacy of preventive migraine treatments
por: Ailani, Jessica, et al.
Publicado: (2022)

Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Buse, Dawn C., et al.
Publicado: (2023)

Experimental and Clinical Investigation of Cytokines in Migraine: A Narrative Review
por: Yamanaka, Gaku, et al.
Publicado: (2023)

Efficacy, Tolerability, and Safety of DFN‐15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study
por: Lipton, Richard B., et al.
Publicado: (2019)

The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen
por: Breitner, John C. S, et al.
Publicado: (2006)

Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice
por: Oswald, Jessica C, et al.
Publicado: (2018)

Current and emerging evidence-based treatment options in chronic migraine: a narrative review
por: Agostoni, Elio Clemente, et al.
Publicado: (2019)

Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
por: Ailani, Jessica, et al.
Publicado: (2022)

Ayurveda for management of migraine: A narrative review of clinical evidence
por: Soman, Akhila, et al.
Publicado: (2022)

Efficacy and safety of intranasal agents for the acute treatment of migraine: a systematic review and network meta-analysis
por: Li, Guanglu, et al.
Publicado: (2023)

Neuroimaging in the pre-ictal or premonitory phase of migraine: a narrative review
por: Karsan, Nazia, et al.
Publicado: (2023)

Sex hormone-related polymorphisms in endometriosis and migraine: A narrative review
por: van der Vaart, Joy-Fleur, et al.
Publicado: (2022)

Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
por: Ailani, Jessica, et al.
Publicado: (2023)

A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine
por: Bhambri, Rahul, et al.
Publicado: (2015)

Patient‐identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient‐centered outcome
por: Lipton, Richard B., et al.
Publicado: (2021)

Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials
por: Loo, Li Shen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p9mf5p1rp6ncvfc4311aq15br0